The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Furnace and Directorate Change

20 Dec 2019 07:00

RNS Number : 5670X
Falanx Group Limited
20 December 2019
 

19 December 2019

 

FALANX GROUP LIMITED

 

("Falanx", the "Group" or the "Company")

 

Sale of Furnace and Directorate Change

 

 

Falanx Group Limited (AIM: FLX), the global cyber security and intelligence services provider, has sold its serverless stream processing platform, Furnace ("Furnace"), to a team led by Falanx's Chief Strategy Officer and Founder, John Blamire. As part of the sale, John Blamire has resigned from the Board with immediate effect. Following the sale, Falanx will continue to benefit from Furnace technology through licensing and support agreements.

 

Background to the sale

 

Furnace allows users to span the rapidly growing array of Cloud technology, increasingly used by business. Over the last few years, Falanx has built a serverless platform to provide businesses of all sizes and their in-house developers with the tools to build high volume, data driven applications, such as required in Security Monitoring, IoT, Marketing and Finance. Furnace aims to assist enterprises in improving performance, visibility of risks and reducing costs regardless of the location or type of data.

 

Whilst the Board remains of the view that there is a strong potential market opportunity for Furnace, it has determined that Furnace, which is pre-revenue and loss making, is non-core to Falanx's cyber services market. Accordingly, the Board has resolved to sell Furnace to a team led by Falanx's Chief Strategy Officer and Founder, John Blamire and Falanx Technologies Chief Technology Officer and Furnace's lead architect, Daniel Waite.

 

In the interim accounts to 30 September 2019, Falanx has capitalised R&D costs of c.£1.2m relating to Furnace together with goodwill on the balance sheet of c.£400k. For the first eight months of the current financial year, Furnace made a loss of £193,000 and received capital investment of £218,000.

 

The sale of Furnace will reduce Falanx's cash expenditure requirements whilst providing mechanisms to protect not only its investment to date but to ensure that Falanx benefits materially from any increase in value. As part of the transaction, John Blamire and Daniel Waite as well as certain external contractors will be transferring with the business with immediate effect.

 

The transaction

 

Falanx is selling the business and assets of Furnace to Furnace Technologies Limited (a company controlled by John Blamire and Daniel Waite) for a sale price of £1.1m, to be funded by way of an unsecured loan note, plus the issue and allotment to Falanx of 20% of the shares in Furnace Technologies Limited. The loan note has a five year term and carries a 5% coupon. Furthermore, in the event that Furnace is sold during the five years following the initial sale by Falanx, Falanx would receive an additional 20% of the proceeds of a sale in the first 12 months, amortising down to zero over the remaining four years. Falanx also benefits from certain accelerated loan repayment arrangements in the event of a sale or change of control in Furnace. This will mean a reclassification of Falanx's current R&D and other intangibles to investments.

 

Related party transaction

 

The sale of Furnace to Furnace Technologies Limited, a company in which John Blamire is a substantial shareholder and director, is a related party transaction pursuant to rule 13 of the AIM Rules for Companies. Accordingly, the Directors of Falanx (excluding John Blamire) having consulted with the Company's nominated adviser, Stifel, consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

Mike Read, Chief Executive Officer of Falanx, commented:

 

"Whilst Furnace is an exciting platform with a potentially large market opportunity, it is non-core to the Group's cyber focus. The sale will reduce Falanx's cash expenditure whilst ensuring that Falanx benefits materially from any increase in value. We believe that through the management buy-out, John and his team will be able to better focus and exploit its potential in addition to freeing Falanx to progress its core Cyber services business. We wish John and the team, who are business associates and good personal friends, the best of luck with this project."

 

John Blamire, Chief Executive Officer of Furnace, commented:

 

"I am sad to be leaving Falanx which I brought to IPO in 2013 and would like to thank every member of the Falanx team for their support, loyalty and hard work over the years. I am also tremendously excited by the opportunity Furnace represents, not only in continuing to support the growth of Falanx and its technology requirements but also in its vast potential beyond the realms of Cyber Security."

 

ends

Enquiries:

 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Alex Price / Fred Walsh / Neil Shah

 

+ 44 (0) 207 710 7600

Turner Pope International Limited, Joint Broker

James Pope / Ben Turner

 

+44 (0) 203 621 4120

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring / Zach Cohen

+44 (0) 203 934 663

 

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: http://www.falanx.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISGGGCCPUPBGBB
Date   Source Headline
18th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20212:05 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:06 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSTriarii to include Microsoft Azure Sentinel
18th Dec 20207:00 amRNSUpdate on SolarWinds® Orion® Platform Cyberattack
17th Dec 20202:28 pmRNSResult of AGM
17th Dec 20207:00 amRNSInterim results
1st Dec 20207:00 amRNSTotal Voting Rights
23rd Nov 202010:12 amRNSNotice of AGM
4th Nov 20204:42 pmRNSDirector subscriptions/PDMR dealing and TVR
30th Oct 20204:17 pmRNSPublication of final results & total voting rights
30th Oct 20207:00 amRNSPreliminary results for year ended 31 March 2020
28th Oct 20207:00 amRNSFalanx joins SolarWinds TAP
2nd Oct 20201:53 pmRNSHolding(s) in Company
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20202:21 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSConfirmation of successful fundraising
28th Sep 20204:55 pmRNSProposed Equity Fundraise
18th Sep 20207:00 amRNSStrategic Contract Win
21st Aug 202012:16 pmRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSStrategic Contract Win
5th Aug 20207:00 amRNSTrading Statement
24th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20207:00 amRNSHolding(s) in Company
9th Jul 20202:19 pmRNSHolding(s) in Company
21st Apr 20207:00 amRNSSalary sacrifice, grant of options & PDMR dealing
27th Feb 202011:56 amRNSHolding(s) in Company
2nd Jan 20203:21 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSSale of Furnace and Directorate Change
3rd Dec 20194:40 pmRNSResult of AGM
3rd Dec 20197:00 amRNSInterim Results
22nd Nov 201910:18 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSTrading update, notice of results & notice of AGM
25th Sep 20197:30 amRNSGrant of Share Options
25th Sep 20197:00 amRNSDirector/PDMR Shareholding
24th Sep 201911:37 amRNSDirector/PDMR Shareholding
23rd Sep 20193:13 pmRNSAvailability of report and accounts
19th Sep 20197:00 amRNSAnnual results for the year ended 31 March 2019
31st May 201911:39 amRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSChange of Adviser
28th Mar 20197:00 amRNSDirectorate Change
22nd Mar 20197:00 amRNSChange of Adviser
18th Feb 201910:32 amRNSDirector / PDMR Shareholding
18th Feb 201910:18 amRNSDirector / PDMR Shareholding
21st Dec 20181:01 pmRNSGrant of Share Options
21st Dec 201812:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.